Article Per Year (5 Year)
p-Index From 2020 - 2025
0.408
P-Index
This Author published in this journals
All Journal PENDIPA Journal of Science Education
Ruskar, Dandung
Unknown Affiliation
Chemistry Education Mathematics

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Optimalisasi Lembaga Farmasi TNI AL Dalam Produksi Sediaan Farmasi Guna Mendukung Ketahanan Kesehatan Ruskar, Dandung; Kumala, Shirly; Noor, Laili Savitri
PendIPA Journal of Science Education Vol 9 No 1 (2025): February
Publisher : UNIB Press

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33369/pendipa.9.1.132-139

Abstract

RIPIN (National Industrial Development Master Plan) 2015-2035 has placed the Pharmaceutical Industry as one of the priority industries to be developed. Meanwhile, the results of the ASEAN Summit in September 2023 held in Jakarta stated that Indonesia had the lowest score for indicators of drug availability and costs, which was 54.02. The existence of BPJS Kesehatan in 2014 greatly reduced the role and function of the Navy Pharmaceutical Institution as the pharmaceutical industry owned by the TNI AL. Currently, Lafial only produces pharmaceutical preparations for health support whose need is very limited because the state budget received is also reduced. In order to support and increase the availability of medicines in Indonesia, the role and function of Lafial should be utilized. The purpose of this study was to design the right business strategy for Lafial to meet the needs of national medicines while reducing dependence on the state budget through SWOT analysis and QSPM matrix. This was qualitative research using a descriptive analysis approach to further explore the internal and external parameters factors of Lafial. The data collection technique used was triangulation from in-depth interviews and FGDs on key personnel pharmacists as well as questionnaires through Google Forms for all pharmacists outside key personnel and secondary data collection. The results of the study on the strength component score was 2.022; the weakness component was 1.540; the opportunity component was 2.020 and the threat component was 1.673. With these results, Lafial's position is in cell number I of the IE matrix and quadrant I of the SWOT quadrant. The strategy analysis using QSPM provides that the strategy of sharpening market penetration through coordination with the Officials and Heads of the Navy health facilities to use Lafial's finished products has the highest TAS value with a value of 5,611. Then the strategy of developing the market through coordination with the Ministry of Health and the Ministry of Finance to be able to produce and deposit PNBP has a TAS value of 5.204. The last strategy is a strategy to increase operational efficiency through coordination with the state-owned and private pharmaceutical industry through drug toll manufacturing activities with a TAS value of 4.332.
RANCANGAN STRATEGI LEMBAGA FARMASI TNI AL DALAM MEMASUKI PASAR FARMASI NASIONAL: Rancangan Strategi Lembaga Farmasi TNI AL Dalam Memasuki Pasar Farmasi Nasional Ruskar, Dandung; Kumala, Shirly; Noor, Laili Savitri
PendIPA Journal of Science Education Vol 9 No 1 (2025): February
Publisher : UNIB Press

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33369/pendipa.9.1.240-249

Abstract

The growth of the pharmaceutical market in Indonesia provides a positive trend. It is increasing along with the increase in population, public awareness of health, and people's purchasing power. Supported by the government's seriousness to improve services in the health sector, making the pharmaceutical industry one of the priority non-oil and gas industries and included in the National Industrial Development Master Plan (RIPIN) 2015-2035. This positive market growth is in stark contrast to the current growth of the pharmaceutical industry. According to data from the Central Statistics Agency (BPS), the pharmaceutical industry in Indonesia has experienced very slow growth, namely by 0.7% in 2022 and by 0.1% in 2023. The ASEAN Summit in September 2023 also placed Indonesia as a country with the lowest score for the availability of medicines. The Navy Pharmaceutical Institute (Lafial) as a pharmaceutical industry owned by the Navy has great potential to be utilized. Moreover, Lafial's current condition requires increasing production capacity to get other budgets apart from the state budget by participating in the Indonesian pharmaceutical market. This research aims to obtain a business strategy for Lafial to be able to participate in the Indonesian pharmaceutical market and despite the current less conducive conditions. This research uses SWOT analysis as a method which is then followed by using the QSPM matrix. This research is a qualitative descriptive analysis to explore the components of internal and external factors owned by Lafial. The data used are data obtained from interviews, FGDs, questionnaires, and secondary data. This study provides results on the strength component score value of 1.50; the weakness component is 1.98; the opportunity component is 2.08 and the threat component is 1.67. With these results, Lafial's position is in quadrant III of the SWOT quadrant. A strategy analysis using QSPM gave the result that the market switch strategy by improving other functions other than production gave the highest TAS value of 5.05. The second strategy is increasing production capacity through toll manufacturing activities with a TAS value of 4.89. The third strategy is building cooperation with the TNI Navy cooperative with a TAS value of 4.81 and the last strategy is to transform into a sub-task force that can deposit PNBP with a TAS value of 4.22.
Co-Authors Noor, Laili Savitri Shirly Kumala